Ambica Parmar

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Metastatic Renal Cell Carcinoma

Decision Making

Ejection Fraction

Top Venues

Cancer medicine

Cancer reports (Hoboken, N.J.)

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Grace K Grafham, Kenneth J Craddock, Weei-Yuarn Huang, Alexander V Louie, Liying Zhang, David M Hwang, Ambica Parmar
Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada. Cancer medicine 13 (3) (2024)
Grace K Grafham, Kenneth J Craddock, Weei-Yuarn Huang, Alexander V Louie, Liying Zhang, David M Hwang, Ambica Parmar
Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada. Cancer medicine 13 (3) (2024)
Grace K Grafham, Kenneth J Craddock, Weei-Yuarn Huang, Alexander V Louie, Liying Zhang, David M Hwang, Ambica Parmar
Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada. Cancer medicine 13 (3) (2024)
Ambica Parmar, Brandon Lu, Jin Luo, Kelvin Kar-Wing Chan
Real-world comparative effectiveness and safety of pembrolizumab for PD-L1≥50% metastatic non-small-cell lung cancer. Future oncology (London, England) (2024)
Grace K Grafham, Kenneth J Craddock, Weei-Yuarn Huang, Alexander V Louie, Liying Zhang, David M Hwang, Ambica Parmar
Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada. Cancer medicine 13 (3) (2024)
Grace K Grafham, Kenneth J Craddock, Weei-Yuarn Huang, Alexander V Louie, Liying Zhang, David M Hwang, Ambica Parmar
Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada. Cancer medicine (2024)
Ambica Parmar, Sunita Ghosh, Arjun Sahgal, Aly-Khan A Lalani, Aaron R Hansen, M Neil Reaume, Lori Wood, Naveen S Basappa, Daniel Y C Heng, Jeffrey Graham, Christian Kollmannsberger, Denis Soulières, Rodney H Breau, Simon Tanguay, Anil Kapoor, Frédéric Pouliot, Georg A Bjarnason
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma. Cancer reports (Hoboken, N.J.) (2022)
Ambica Parmar, Sunita Ghosh, Arjun Sahgal, Aly-Khan A Lalani, Aaron R Hansen, M Neil Reaume, Lori Wood, Naveen S Basappa, Daniel Y C Heng, Jeffrey Graham, Christian Kollmannsberger, Denis Soulières, Rodney H Breau, Simon Tanguay, Anil Kapoor, Frédéric Pouliot, Georg A Bjarnason
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma. Cancer reports (Hoboken, N.J.) 6 (3) (2022)
Ambica Parmar, Sunita Ghosh, Arjun Sahgal, Aly-Khan A Lalani, Aaron R Hansen, M Neil Reaume, Lori Wood, Naveen S Basappa, Daniel Y C Heng, Jeffrey Graham, Christian Kollmannsberger, Denis Soulières, Rodney H Breau, Simon Tanguay, Anil Kapoor, Frédéric Pouliot, Georg A Bjarnason
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma. Cancer reports (Hoboken, N.J.) 6 (3) (2022)
Ambica Parmar, Sunita Ghosh, Arjun Sahgal, Aly-Khan A Lalani, Aaron R Hansen, M Neil Reaume, Lori Wood, Naveen S Basappa, Daniel Y C Heng, Jeffrey Graham, Christian Kollmannsberger, Denis Soulières, Rodney H Breau, Simon Tanguay, Anil Kapoor, Frédéric Pouliot, Georg A Bjarnason
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma. Cancer reports (Hoboken, N.J.) 6 (3) (2022)
Ambica Parmar, Sunita Ghosh, Arjun Sahgal, Aly-Khan A Lalani, Aaron R Hansen, M Neil Reaume, Lori Wood, Naveen S Basappa, Daniel Y C Heng, Jeffrey Graham, Christian Kollmannsberger, Denis Soulières, Rodney H Breau, Simon Tanguay, Anil Kapoor, Frédéric Pouliot, Georg A Bjarnason
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma. Cancer reports (Hoboken, N.J.) 6 (3) (2022)
Cameron M Phillips, Ambica Parmar, Helen Guo, Deborah Schwartz, Wanrudee Isaranuwatchai, Jaclyn Beca, Wei Dai, Jessica Arias, Scott Gavura, Kelvin Kar-Wing Chan
Assessing the efficacy-effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population-based, real-world data for contemporary parenteral cancer therapeutics. Cancer 126 (8) (2020)
Monica Shah, Ambica Parmar, Kelvin Kar-Wing Chan
Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non-small cell lung cancer 2007-2016. Cancer medicine 9 (10) (2020)
Ambica Parmar, Kelvin K W Chan
Health technology assessment methodology in metastatic renal cell carcinoma. Nature reviews. Urology 17 (1) (2020)
Ambica Parmar, Tina Jiao, Ronak Saluja, Kelvin Kar-Wing Chan
Value-based pricing: Toward achieving a balance between individual and population gains in health benefits. Cancer medicine 9 (1) (2019)